Table of Contents
<< Previous Issue | Jan 2004 (Vol: 2004, Issue: 43) | Next Issue >> |
- Section: Company Profile
-
Fujisawa Pharmaceutical Co. Ltd
- Section: Distribution & Marketing
-
Yamanouchi to Market Aventis’ Peptic Ulcer Drug Amidst Merger Talks
- Section: Licensing
-
CAT Poised to Take Legal Action Against Abbott
-
Roche Reinvigorates Anti-Infective Franchise with Sankyo’s Antibiotic
-
Norwood Abbey Licenses Technology to TAP Pharmaceutical Products
-
CIMA Labs Licenses Fast-Dissolving Fentanyl to Taiho
- Section: Mergers & Acquisitions
-
Lilly Acquires AME to Optimize its Pipeline Proteins
- Section: Research & Development
-
Celltech Regains Drug Rights from Pfizer